The Cancer Genomics Program at the Princess Margaret Cancer Centre is dedicated to advancing personalized cancer medicine through the identification of genetic mutations and molecular mechanisms that drive cancer.
Our ultimate vision is to have all patients who may benefit from this approach undergo comprehensive molecular characterization of their cancer.